New active substances expand the treatment options for MS
Hellwig, B.
Medizinische Monatsschrift für Pharmazeuten 38(2): 65-68
2015
ISSN/ISBN: 0342-9601 PMID: 26376542 Document Number: 682882
Document emailed within 1 workday
Related Documents
Griazina, A.G.; Gluzman, E.M.; Andreeva, L.A. 1973: Release of active substances from emulsified ointment bases containing, as emulsifiers, a new class of surface-active substances Vestnik Dermatologii i Venerologii 47(7): 56-58Freiherr, G. 1996: Multipurpose rooms expand imaging options Diagnostic Imaging Suppl: IR6-IR8
Dakins, D.R. 1990: Gallstone therapy options expand beyond lithotripsy Diagnostic Imaging 12(4): 96-104
Jarzebiński, J.; Suchocki, P.; Kurbiedź, E. 1978: Use of densitometry in the determination of active substances in drugs. II. Determination of active substances in various compounded analgesics and antipyretics Acta Poloniae Pharmaceutica 35(4): 453-459
Bayliss, D.; Duff, J.; Stricker, P.; Walker, K. 2016: Decision-Making in Prostate Cancer: Active Surveillance over other Treatment Options Urologic Nursing 36(3): 141-149
Chaplygina, Z.A.; Kochetygov, N.I.; Baskovich, G.A.; Gerbut, K.A. 1982: Physiologically active substances in the experiment treatment of hemorrhagic shock Vestnik Khirurgii Imeni I. I. Grekova 128(2): 117-121
Bayliss, D.R.; Duff, J.; Stricker, P.; Walker, K. 2017: Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review Urologic Nursing 37(1): 15-22
Sublett, C.M. 2016: Application to the Evidence Base: Decision-Making in Prostate Cancer: Active Surveillance over other Treatment Options Urologic Nursing 36(3): 150-152
Gostishchev, V.K.; Nikolaev, A.V.; Shekhter, A.B.; Vert'ianov, V.A.; Shapiro, A.M. 1986: Diadynamophoresis of chemical and biologically active substances in the treatment of suppurative and inflammatory diseases in diabetes mellitus Vestnik Khirurgii Imeni I. I. Grekova 137(8): 63-66
Masliuk, V.I.; Polosova, T.A.; Neporent, M.I.; Abbakumov, S.A.; Shatikhin, A.I. 1977: Effect of treatment with cardiac glycosides and biologically active substances on the state of the lesser circulation according to the electrokymographic data Kardiologiia 17(9): 42-46
Kallis, A.A. 2003: To Expand or not to Expand? Territory, Generic Fascism and the Quest for an `Ideal Fatherland' Journal of Contemporary History 38(2): 237-260
2008: Tipranavir optimizes the effect of recent antiretroviral substances. Encouraging options in multiple resistance MMW Fortschritte der Medizin 150 Spec No 1: 71
Haas, H. 1970: Studies on coronary-active substances Arzneimittel-Forschung 20:Suppl.9a: 1299+
Frohne, D. 1977: Pharmacologically active substances from cactaceae Deutsche Medizinische Wochenschrift 102(22): 849
Liu, Q.; Hu, J.; Xue, D.; Ma, C.; Wang, S. 2002: Bio-active substances derived from marine microorganisms Ying Yong Sheng Tai Xue Bao 13(7): 901-905
Wiśniewski, K. 1979: Some aspects of interaction of biologically active substances in the CNS Polish Journal of Pharmacology and Pharmacy 31(4): 347-358
Groeger, U.; Lang, S.; Michel, H.J. 1981: On the calculation and the evaluation of combinations of active substances Die Pharmazie 36(2): 81-87
Beliavskaia, L.A.; Kozyritskaia, V.E.; Valagurova, E.V.; Iutinskaia, G.A. 2012: Biologically active substances of preparation avercom Mikrobiolohichnyi Zhurnal 74(3): 10-15
Jiang, Z.; Chen, Q.-C.; Cao, L.-X.; Chen, Z.-Q. 2013: Advance in studies on areca nuts and their active substances Zhongguo Zhong Yao Za Zhi 38(11): 1684-1687
Korneĭchuk, E.P.; Datsenko, I.I.; Petrus, V.S. 1988: Determining the toxicity of biologically active chemical substances Gigiena i Sanitariia 9: 38-39